Rociletinib

. N-(3-{[2-{[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5- (trifluoromethyl)pyrimidin-4-yl]amino}phenyl)prop-2-enamide

1374640-70-6

2-Propenamide, N-[3-[[2-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-

72AH61702G

N-(3-{[2-{[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino}-5-(trifluormethyl)-4-pyrimidinyl]amino}phenyl)acrylamid

N-(3-{[2-{[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)-4-pyrimidinyl]amino}phenyl)acrylamide

N-(3-{[2-{[4-(4-Acétyl-1-pipérazinyl)-2-méthoxyphényl]amino}-5-(trifluorométhyl)-4-pyrimidinyl]amino}phényl)acrylamide

N-{3-[(2-{[4-(4-ACETYLPIPERAZIN-1-YL)-2-METHOXYPHENYL]AMINO}-5-(TRIFLUOROMETHYL)PYRIMIDIN-4-YL)AMINO]PHENYL}PROP-2-ENAMIDE

Rociletinib

rociletinib

rocilétinib

rociletinibum

роцилетиниб

روسيليتينيب

罗西替尼

ALK tyrosine kinase receptor

ALK_HUMAN

AVL-301;CNX-419

AVL-301;CNX-419; Rociletinib

CO-1686 (AVL-301)

EGFR

EGFR_HUMAN

Epidermal growth factor receptor

Methyl 3-nitro-1-naphthoate

MFCD26793864

N-(3-((2-((4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide

N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide

N-[3-[[2-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide

Rociletinib (CO-1686, AVL-301)

Rociletinib(AVL-301,CNX-419,CO-1686)

Rociletinib;AVL-301;CNX-419